Masahiro Tanji

1.3k citations
61 papers · 920 indexed · h-index 12
Topics
Glioma Diagnosis and Treatment (16 papers)Pituitary Gland Disorders and Treatments (10 papers)Meningioma and schwannoma management (9 papers)

In The Last Decade

Masahiro Tanji

43 papers receiving 903 citations

Peers

Masahiro Tanji
Comparison fields: 5 of 86
  • Molecular Biology 444
  • Cell Biology 323
  • Oncology 134
  • Cancer Research 104
  • Immunology and Allergy 100
Replace Li‐Kun Phng with:
Li‐Kun Phng Japan
Nieves Movilla Spain
Alexia-Ileana Zaromytidou United States
Daniel N. Duong United States
Bertrand Vernay United Kingdom
Liang Weng China
Jovencio Borneo United States
Ksenija Drabek Netherlands
Susana de Vega Japan
Keisuke Sako Japan
Masahiro Tanji relative to Li‐Kun Phng Japan Li‐Kun Phng's profile →
Citations per field
00.5×1.5×
Li‐Kun Phng · 1×
Citations per year

Countries citing papers authored by Masahiro Tanji

Since Specialization
Citations

This map shows the geographic impact of Masahiro Tanji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Tanji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Tanji more than expected).

Fields of papers citing papers by Masahiro Tanji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Tanji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Tanji. The network helps show where Masahiro Tanji may publish in the future.

Co-authorship network of co-authors of Masahiro Tanji

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Tanji. A scholar is included among the top collaborators of Masahiro Tanji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Tanji. Masahiro Tanji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 3
6 7
7 0
8 0
9 4
10 9
11 4
12 1
13 15
14 2
15 0
16 23
17 29
18 10
19 4
20 2

About Masahiro Tanji

Masahiro Tanji is a scholar working on Genetics, Neurology and Endocrinology, Diabetes and Metabolism, having authored 61 papers that have together received 920 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (16 papers), Pituitary Gland Disorders and Treatments (10 papers) and Meningioma and schwannoma management (9 papers). The work is most often cited by research in Cell Biology (323 citations), Immunology and Allergy (100 citations) and Genetics (83 citations). Masahiro Tanji has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Shuh Narumiya, Toshimasa Ishizaki, Yoshiki Arakawa, Susumu Miyamoto, Haruhiko Bito, Nobuo Hashimoto, Yohei Mineharu, Reina E. Itoh, Kazuo Kurokawa and Tomohiro Nishino. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026